Rising Health Concerns: GLP-1 Weight-Loss Drugs Linked to Nutrient Deficiencies
New research reveals GLP-1 weight-loss drugs may cause critical nutrient deficiencies in millions of users. Learn about the risks to health and development.
POLICY WIRE — Washington, USA — A growing body of scientific research indicates that individuals using GLP-1 medications for weight management and diabetes treatment are facing significant nutrient deficiencies. With nearly 30 million Americans currently prescribed these drugs, experts are raising alarms about the potential long-term impact on patient health.
An August review conducted by researchers at the Harvard T.H. Chan School of Public Health and the University of Copenhagen identified critical shortfalls in vitamin B12, protein, and fiber among users. These nutrients are essential for nerve protection, muscle and organ repair, and digestive health.
The study authors emphasized the necessity of clinical intervention, stating, As GLP-1 prescriptions reach millions of patients across diverse and often under-resourced clinical settings, integrating nutrition into this care model is not just advisable; it is urgent.
Data from Ohio State University suggests that 10 million Americans already struggle with insufficient B12 levels, a risk that intensifies for GLP-1 users who follow plant-based diets. Furthermore, the review found that 43 percent of users consume inadequate protein, while insufficient fiber intake often triggers nausea, bloating, and constipation, creating a cycle in which patients eat even less.
The Mayo Clinic notes that protein and fiber are vital for maintaining healthy weight and regulating blood sugar to prevent diabetes. The issue extends to younger populations as well; American children under 12 are now using GLP-1 drugs at 300 times the rate observed seven years ago.
A September study from Northwestern University revealed that nearly one in six children aged 10 to 17 who used these medications for a year developed nutrient deficiencies. Vitamin D deficiency was the most common complication, which researchers noted is particularly concerning during adolescence due to its role in skeletal health and development.
The study authors noted, Nutrients such as vitamin D, iron, and calcium are of particular concern during adolescence, when deficiencies may have lasting implications for skeletal health and development.
Adults are also susceptible to these deficits. A January review of over 480,000 adults found that 13.6 percent suffered from vitamin D deficiency after one year of treatment, a trend that poses risks for bone density as patients age.
According to the Cleveland Clinic, untreated nutrient deficiencies can lead to severe health outcomes, including stunted growth and soft bones. Common warning signs include fatigue, weakness, hair loss, skin rashes, and reduced heart rate.
Reporting by Policy-Wire (PW)





